251 related articles for article (PubMed ID: 20979454)
21. Immune responses to intradermal and intramuscular inactivated influenza vaccine among older age group.
Boonnak K; Dhitavat J; Thantamnu N; Kosoltanapiwat N; Auayporn M; Jiang L; Puthavathana P; Pitisuttithum P
Vaccine; 2017 Dec; 35(52):7339-7346. PubMed ID: 29157960
[TBL] [Abstract][Full Text] [Related]
22. Broad and Protective Influenza B Virus Neuraminidase Antibodies in Humans after Vaccination and their Clonal Persistence as Plasma Cells.
Piepenbrink MS; Nogales A; Basu M; Fucile CF; Liesveld JL; Keefer MC; Rosenberg AF; Martinez-Sobrido L; Kobie JJ
mBio; 2019 Mar; 10(2):. PubMed ID: 30862743
[TBL] [Abstract][Full Text] [Related]
23. Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study.
McVernon J; Laurie K; Barr I; Kelso A; Skeljo M; Nolan T
Influenza Other Respir Viruses; 2011 Jan; 5(1):7-11. PubMed ID: 21138535
[TBL] [Abstract][Full Text] [Related]
24. Safety and immunogenicity of the novel seasonal preservative- and adjuvant-free influenza vaccine: Blind, randomized, and placebo-controlled trial.
Sarsenbayeva G; Volgin Y; Kassenov M; Issagulov T; Bogdanov N; Sansyzbay A; Abitay R; Nurpeisova A; Sagymbay A; Koshemetov Z; Stukova M; Buzitskaya Z; Кulmagambetov I; Karabayeva D; Davlyatshin T; Khairullin B
J Med Virol; 2018 Jan; 90(1):41-49. PubMed ID: 28842994
[TBL] [Abstract][Full Text] [Related]
25. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
[TBL] [Abstract][Full Text] [Related]
26. Immunological persistence of a seasonal influenza vaccine in people more than 3 years old.
Bai Y; Shi N; Lu Q; Yang L; Wang Z; Li L; Han H; Zheng D; Luo F; Zhang Z; Ai X
Hum Vaccin Immunother; 2015; 11(7):1648-53. PubMed ID: 26083828
[TBL] [Abstract][Full Text] [Related]
27. Preexisting Immunity, Not Frailty Phenotype, Predicts Influenza Postvaccination Titers among Older Veterans.
Van Epps P; Tumpey T; Pearce MB; Golding H; Higgins P; Hornick T; Burant C; Wilson BM; Banks R; Gravenstein S; Canaday DH
Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28100496
[TBL] [Abstract][Full Text] [Related]
28. Low response in eliciting neuraminidase inhibition activity of sera among recipients of a split, monovalent pandemic influenza vaccine during the 2009 pandemic.
Ito H; Nishimura H; Kisu T; Hagiwara H; Watanabe O; Kadji FMN; Sato K; Omiya S; Takashita E; Nobusawa E
PLoS One; 2020; 15(5):e0233001. PubMed ID: 32401814
[TBL] [Abstract][Full Text] [Related]
29. Serologic status for pandemic (H1N1) 2009 virus, Taiwan.
Huang DT; Shao PL; Huang KC; Lu CY; Wang JR; Shih SR; Chi H; Lai MR; Lee CY; Chang LY; Huang LM
Emerg Infect Dis; 2011 Jan; 17(1):76-8. PubMed ID: 21192858
[TBL] [Abstract][Full Text] [Related]
30. Immunogenicity of a monovalent pandemic influenza A H1N1 virus vaccine with or without prior seasonal influenza vaccine administration.
Igari H; Watanabe A; Segawa S; Suzuki A; Watanabe M; Sakurai T; Watanabe M; Tatsumi K; Nakayama M; Suzuki K; Sato T
Clin Vaccine Immunol; 2012 Oct; 19(10):1690-2. PubMed ID: 22855394
[TBL] [Abstract][Full Text] [Related]
31. Protective efficacy against pandemic influenza of seasonal influenza vaccination in children in Hong Kong: a randomized controlled trial.
Cowling BJ; Ng S; Ma ES; Fang VJ; So HC; Wai W; Cheng CK; Wong JY; Chan KH; Ip DK; Chiu SS; Peiris JS; Leung GM
Clin Infect Dis; 2012 Sep; 55(5):695-702. PubMed ID: 22670050
[TBL] [Abstract][Full Text] [Related]
32. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
Walz L; Kays SK; Zimmer G; von Messling V
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
[TBL] [Abstract][Full Text] [Related]
33. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of T and B memory cell responses elicited by the pandemic H1N1 vaccine in HIV-infected and HIV-uninfected individuals.
Sun P; Crum-Cianflone NF; Defang G; Williams M; Ganesan A; Agan BK; Lalani T; Whitman T; Brandt C; Burgess TH
Vaccine; 2017 Oct; 35(45):6103-6111. PubMed ID: 28987439
[TBL] [Abstract][Full Text] [Related]
35. CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection.
Schmidt T; Dirks J; Enders M; Gärtner BC; Uhlmann-Schiffler H; Sester U; Sester M
Eur J Immunol; 2012 Jul; 42(7):1755-66. PubMed ID: 22585549
[TBL] [Abstract][Full Text] [Related]
36. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
[TBL] [Abstract][Full Text] [Related]
37. Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals.
Desheva Y; Sychev I; Smolonogina T; Rekstin A; Ilyushina N; Lugovtsev V; Samsonova A; Go A; Lerner A
PLoS One; 2018; 13(5):e0196771. PubMed ID: 29742168
[TBL] [Abstract][Full Text] [Related]
38. Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine.
Chen GL; Lau YF; Lamirande EW; McCall AW; Subbarao K
Proc Natl Acad Sci U S A; 2011 Jan; 108(3):1140-5. PubMed ID: 21199945
[TBL] [Abstract][Full Text] [Related]
39. Similar immunogenicity of the A/H1N1 2009 pandemic influenza strain when used as a monovalent or a trivalent vaccine.
Van der Vliet D; Pepin S; Lambert M; Fauchoux N; Donazzolo Y; Dupuy M; Dakowski C; Denis M
Hum Vaccin; 2010 Oct; 6(10):823-8. PubMed ID: 20935517
[TBL] [Abstract][Full Text] [Related]
40. Repeated Influenza Vaccination Boosts and Maintains H1N1pdm09 Neuraminidase Antibody Titers.
Hansen L; Zhou F; Amdam H; Trieu MC; Cox RJ
Front Immunol; 2021; 12():748264. PubMed ID: 34721417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
